The GOAL27-6 Study
NCT05859828 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2023-08-25
Summary
The main purpose and goal of this study is to find out if a particular course of radiotherapy for non-curable cancers, together with palliative care support, can help improve patients' quality of life.
Conditions
Sponsors & Collaborators
-
Get A-Head Charitable Trust
collaborator UNKNOWN -
East and North Hertfordshire NHS Trust
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-04-21
- Primary Completion
- 2024-04-21
- Completion
- 2025-04-21
Countries
- United Kingdom
Study Locations
More Related Trials
-
Changes to Function and Quality of Life and Patient Experience for Patients Undergoing Treatments for Recurrent Oropharyngeal Cancer
NCT04952922 ·Status: COMPLETED
-
Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers
NCT04747054 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC
NCT06100497 ·Status: RECRUITING ·Phase: PHASE2
-
Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck
NCT02474368 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition
NCT04454489 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck
NCT04435938 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx
NCT02055989 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer
NCT00629226 ·Status: COMPLETED ·Phase: PHASE1
-
Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese Subjects
NCT01012258 ·Status: COMPLETED ·Phase: PHASE3
-
Big Data for Quality of Life in Head and Neck Cancer
NCT05315570 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Body Radiation Therapy Using HyperArc in Treating Patients With Recurrent Head and Neck Cancer
NCT03892720 ·Status: COMPLETED ·Phase: NA
-
A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC
NCT03678649 ·Status: UNKNOWN ·Phase: PHASE2
-
Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma
NCT06308913 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
NCT01345682 ·Status: COMPLETED ·Phase: PHASE3
-
Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00625937 ·Status: UNKNOWN ·Phase: PHASE2
-
Single and Combined Modality Trans-Oral Robotic Surgery in Early Oropharyngeal Cancer
NCT05933889 ·Status: RECRUITING
-
A Web-Based Multimedia Intervention for Head and Neck Cancer Patients
NCT02442336 ·Status: COMPLETED ·Phase: NA
-
Studying Survivorship Care Plans in Head and Neck Cancer
NCT03106090 ·Status: TERMINATED ·Phase: NA
-
Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life
NCT06136962 ·Status: NOT_YET_RECRUITING
-
Chemo-embolization for Head and Neck Cancer
NCT04595981 ·Status: WITHDRAWN ·Phase: PHASE2
-
Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC
NCT00162708 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer
NCT03032250 ·Status: COMPLETED ·Phase: NA
-
Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC
NCT05446467 ·Status: RECRUITING ·Phase: PHASE2
-
Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer
NCT05551767 ·Status: UNKNOWN ·Phase: PHASE2
-
Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada
NCT02705833 ·Status: COMPLETED